ADMA - ADMA Biologics hits 52-week high on Q1 beat guidance raise
2024-05-10 15:31:43 ET
More on ADMA Biologics
- ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Call Transcript
- Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)
- ADMA Biologics, Inc. (ADMA) Q4 2023 Earnings Call Transcript
- ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M
- ADMA Biologics Q1 2024 Earnings Preview